期刊文献+

喹诺酮类药致老年人不良反应文献分析 被引量:10

Literature Analysis on ADR Induced by Quinolones in the Elderly
原文传递
导出
摘要 目的:了解喹诺酮类药致老年人不良反应发生的情况。方法:以"喹诺酮"、"沙星"为题名,检索《中国医院数字图书馆》2004~2009年中有关喹诺酮类药致老年人(≥60岁)不良反应的文献资料137篇,共173例,并按涉及药品种类、患者年龄、性别、给药途经、原患疾病、不良反应发生时间、累及系统及临床表现等进行统计分析。结果:引起不良反应的喹诺酮类药共有12种;以男性居多(63.01%);60~65岁老年人发生不良反应较多(30.06%);多表现为神经系统反应(33.53%)、变态反应(20.81%)、内分泌系统反应(17.34%),精神异常和癫痫是神经系统不良反应的主要表现(75.86%);死亡2例。结论:临床应重视喹诺酮类药在老年人中引起的不良反应,警惕严重不良反应(过敏性休克)的发生。 OBJECTIVE: To explore the status quo of ADR induced by quinolones in the elderly. METHODS: Retrieved from CNKI database with "quinolones" or "oxacin" as key words, 137 literatures about 173 ADR cases induced by quinolones in the elderly were statistically analyzed in respects of category of drugs, patients’ age and sex, route of administration, primary disease, occurrence time of ADR, organs and systems involved in ADR and clinical manifestation, etc. RESULTS: 12 kinds of quinolones were involved in ADR cases. 63.01% cases were male and 30.06% cases were the elderly (aged from 60 to 65). Main ADR manifested nervous reaction (33.53%), allergic reaction (20.81%) and pathoglycemia (17.34%). The main clinical manifestations of ADR in the nervous system were abnormal mental status and epilepsy (75.86%). Two cases were dead. CONCLUSION: Great importance should be attached to the ADR induced by quinolones in the elderly and occurrence of severe ADR (anaphylactic shock).
作者 范铭
出处 《中国药房》 CAS CSCD 北大核心 2010年第18期1704-1706,共3页 China Pharmacy
关键词 喹诺酮类药 药品不良反应 老年人 文献分析 Quinolones ADR Elderly Literature analysis
  • 相关文献

参考文献4

二级参考文献51

  • 1王浴生,周黎明.喹诺酮类抗菌药毒理学与临床不良反应的几个问题[J].四川生理科学杂志,2004,26(3):123-124. 被引量:17
  • 2[1]Wilson AP,Gruneberg RN.Ciprofloxacin:10 years of clinical experience.London:Oxford,1997:1.
  • 3[2]Schellhorn C.Classification of quinolones by V.Andrionle.Infection,1998,26:63.
  • 4Halliwell RF, Davery PG, Lambert JJ. Antagonism of GABA receptor by 4-quinolones[J]. J Antimicrob Chemother, 1993, 31: 457.
  • 5Domagala JM. Structure-activity and structure-side-effect relationships for quinolone antibacterials [J]. J Antimicroh Chemother, 1994, 23: 685.
  • 6William PD, Helton DR. The proconvulsive activity of quinolone antibiotics in an animal model [J]. Toxicol Lett, 1991, 58: 21.
  • 7Schmuck G, Schurmann A, Schluter G, et al. Determination of the excitatory potencyes of different fluoroquinolones in the central nervous system by an in vitro model[J]. Antimicrob Agents Chemother, 1998, 42 :1831.
  • 8Hod S, Shimida J, Sato A, et al. Comparison of the inhibitory effects of new quinolone on gamma-aminobu-tyric acid receptor binding in the presence of anti-inflammatory drugs[J]. Rev Infect Dis, 1989, ( Suppl 5 ) :S1397.
  • 9Robinstein E, Camm J. Cardiotoxicity of fluoroquinolones[J]. J Antimicrob Chemother, 2002,49: 593.
  • 10Hagiwara T, Satch S, Kasai Y, et al. A comparative study of the fluoroquinolone antibacterial agents on the action potential duration in guinea pig ventricular myocardia[J]. Jpn J Pharmacol, 2001,87: 231.

共引文献67

同被引文献94

引证文献10

二级引证文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部